In primary CD34+ MDS BM cells (n = 21) expression of KDM2B and EZH2 mRNA was lower than in CD34+ BM cells from healthy donors (n = 11; p = 0.012 and <0.0001, respectively). Here, KDM2B is linked to myelodysplastic syndrome.